AUD 0.29
(-6.45%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | -338 Thousand AUD | 94.48% |
2023 | -6.12 Million AUD | -551.14% |
2022 | 1.35 Million AUD | 35.97% |
2021 | 998 Thousand AUD | 117.09% |
2020 | -5.83 Million AUD | -245.37% |
2019 | 4.01 Million AUD | 44.25% |
2018 | 2.78 Million AUD | 113.33% |
2017 | 1.3 Million AUD | -60.13% |
2016 | 3.27 Million AUD | 66.14% |
2015 | 1.97 Million AUD | 116.72% |
2014 | 909 Thousand AUD | 161.05% |
2013 | -1.48 Million AUD | 47.37% |
2012 | -2.82 Million AUD | -3592.59% |
2011 | 81 Thousand AUD | -80.43% |
2010 | 414 Thousand AUD | -84.82% |
2009 | 2.72 Million AUD | 260.71% |
2008 | 756 Thousand AUD | 514.63% |
2007 | 123 Thousand AUD | 107.71% |
2006 | -1.59 Million AUD | 59.08% |
2005 | -3.89 Million AUD | -262.64% |
2004 | 2.39 Million AUD | 112.92% |
2003 | -18.55 Million AUD | -877.7% |
2002 | -1.89 Million AUD | -196.3% |
2001 | 1.97 Million AUD | 2174.74% |
2000 | -95 Thousand AUD | -107.82% |
1999 | 1.21 Million AUD | 54.19% |
1998 | 788 Thousand AUD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 FY | -499 Thousand AUD | 91.85% |
2024 Q2 | 141 Thousand AUD | 0.0% |
2024 Q4 | -640 Thousand AUD | 0.0% |
2023 Q2 | -7.21 Million AUD | 0.0% |
2023 Q4 | 1.09 Million AUD | 0.0% |
2023 FY | -6.12 Million AUD | -551.14% |
2022 Q4 | 1.07 Million AUD | 0.0% |
2022 Q2 | 287 Thousand AUD | 0.0% |
2022 FY | 1.35 Million AUD | 35.97% |
2021 Q4 | -318 Thousand AUD | 0.0% |
2021 FY | 998 Thousand AUD | 117.09% |
2021 Q2 | 1.31 Million AUD | 0.0% |
2020 Q4 | -5.99 Million AUD | 0.0% |
2020 Q2 | 161 Thousand AUD | 0.0% |
2020 FY | -5.83 Million AUD | -245.37% |
2019 FY | 4.01 Million AUD | 44.25% |
2019 Q4 | 3.2 Million AUD | 0.0% |
2019 Q2 | 811 Thousand AUD | 0.0% |
2018 FY | 2.78 Million AUD | 113.33% |
2018 Q4 | 2.14 Million AUD | 0.0% |
2018 Q2 | 641 Thousand AUD | 0.0% |
2017 Q4 | 1.07 Million AUD | 0.0% |
2017 FY | 1.3 Million AUD | -60.13% |
2017 Q2 | 226 Thousand AUD | 0.0% |
2016 Q2 | 1.86 Million AUD | 0.0% |
2016 FY | 3.27 Million AUD | 66.14% |
2016 Q4 | 1.41 Million AUD | 0.0% |
2015 Q4 | 1.06 Million AUD | 0.0% |
2015 FY | 1.97 Million AUD | 116.72% |
2015 Q2 | 904 Thousand AUD | 0.0% |
2014 Q2 | 402 Thousand AUD | 0.0% |
2014 FY | 909 Thousand AUD | 161.05% |
2014 Q4 | 507 Thousand AUD | 0.0% |
2013 FY | -1.48 Million AUD | 47.37% |
2013 Q2 | -767 Thousand AUD | 0.0% |
2013 Q4 | -722 Thousand AUD | 0.0% |
2012 FY | -2.82 Million AUD | -3592.59% |
2012 Q3 | -707.25 Thousand AUD | 0.0% |
2012 Q2 | -707.25 Thousand AUD | -3592.59% |
2012 Q1 | 20.25 Thousand AUD | 0.0% |
2012 Q4 | -707.25 Thousand AUD | 0.0% |
2011 Q3 | 20.25 Thousand AUD | 0.0% |
2011 Q4 | 20.25 Thousand AUD | 0.0% |
2011 FY | 81 Thousand AUD | -80.43% |
2011 Q1 | 103.5 Thousand AUD | 0.0% |
2011 Q2 | 20.25 Thousand AUD | -80.43% |
2010 Q2 | 103.5 Thousand AUD | -84.82% |
2010 Q3 | 103.5 Thousand AUD | 0.0% |
2010 Q4 | 103.5 Thousand AUD | 0.0% |
2010 FY | 414 Thousand AUD | -84.82% |
2010 Q1 | 681.75 Thousand AUD | 0.0% |
2009 FY | 2.72 Million AUD | 260.71% |
2009 Q4 | 681.75 Thousand AUD | 0.0% |
2009 Q2 | 681.75 Thousand AUD | 260.71% |
2009 Q1 | 189 Thousand AUD | 0.0% |
2009 Q3 | 681.75 Thousand AUD | 0.0% |
2008 Q1 | 30.75 Thousand AUD | 0.0% |
2008 FY | 756 Thousand AUD | 514.63% |
2008 Q4 | 189 Thousand AUD | 0.0% |
2008 Q3 | 189 Thousand AUD | 0.0% |
2008 Q2 | 189 Thousand AUD | 514.63% |
2007 FY | 123 Thousand AUD | 107.71% |
2007 Q4 | 30.75 Thousand AUD | 0.0% |
2007 Q3 | 30.75 Thousand AUD | 0.0% |
2007 Q2 | 30.75 Thousand AUD | 107.71% |
2007 Q1 | -398.75 Thousand AUD | 0.0% |
2006 Q1 | -974.41 Thousand AUD | 0.0% |
2006 Q3 | -398.75 Thousand AUD | 0.0% |
2006 Q4 | -398.75 Thousand AUD | 0.0% |
2006 FY | -1.59 Million AUD | 59.08% |
2006 Q2 | -398.75 Thousand AUD | 59.08% |
2005 Q3 | -974.41 Thousand AUD | 0.0% |
2005 Q2 | -974.41 Thousand AUD | -262.63% |
2005 Q4 | -974.41 Thousand AUD | 0.0% |
2005 Q1 | 599.17 Thousand AUD | 0.0% |
2005 FY | -3.89 Million AUD | -262.64% |
2004 Q3 | 599.17 Thousand AUD | 0.0% |
2004 Q2 | 599.17 Thousand AUD | 112.92% |
2004 Q4 | 599.17 Thousand AUD | 0.0% |
2004 Q1 | -4.63 Million AUD | 0.0% |
2004 FY | 2.39 Million AUD | 112.92% |
2003 FY | -18.55 Million AUD | -877.7% |
2003 Q4 | -4.63 Million AUD | 0.0% |
2003 Q3 | -4.63 Million AUD | 0.0% |
2003 Q2 | -4.63 Million AUD | -877.81% |
2003 Q1 | -474.44 Thousand AUD | 0.0% |
2002 Q3 | -474.44 Thousand AUD | 0.0% |
2002 Q4 | -474.44 Thousand AUD | 0.0% |
2002 FY | -1.89 Million AUD | -196.3% |
2002 Q1 | 492.75 Thousand AUD | 0.0% |
2002 Q2 | -474.44 Thousand AUD | -196.28% |
2001 Q2 | 492.75 Thousand AUD | 2174.74% |
2001 FY | 1.97 Million AUD | 2174.74% |
2001 Q3 | 492.75 Thousand AUD | 0.0% |
2001 Q1 | -23.75 Thousand AUD | 0.0% |
2001 Q4 | 492.75 Thousand AUD | 0.0% |
2000 Q4 | -23.75 Thousand AUD | 0.0% |
2000 Q2 | -23.75 Thousand AUD | -107.82% |
2000 Q3 | -23.75 Thousand AUD | 0.0% |
2000 Q1 | 303.75 Thousand AUD | 0.0% |
2000 FY | -95 Thousand AUD | -107.82% |
1999 Q2 | 303.75 Thousand AUD | 54.19% |
1999 FY | 1.21 Million AUD | 54.19% |
1999 Q4 | 303.75 Thousand AUD | 0.0% |
1999 Q1 | 197 Thousand AUD | 0.0% |
1999 Q3 | 303.75 Thousand AUD | 0.0% |
1998 FY | 788 Thousand AUD | 0.0% |
1998 Q2 | 197 Thousand AUD | 0.0% |
1998 Q3 | 197 Thousand AUD | 0.0% |
1998 Q4 | 197 Thousand AUD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
4DMedical Limited | -35.97 Million AUD | 99.061% |
Adherium Limited | -10.22 Million AUD | 96.694% |
Aroa Biosurgery Limited | -9.74 Million AUD | 96.533% |
Atomo Diagnostics Limited | -6.84 Million AUD | 95.064% |
Anteris Technologies Ltd | -67.33 Million AUD | 99.498% |
Control Bionics Limited | -5.91 Million AUD | 94.285% |
CardieX Limited | -6.76 Million AUD | 95.004% |
Cochlear Limited | 356.8 Million AUD | 100.095% |
CleanSpace Holdings Limited | -3.12 Million AUD | 89.191% |
Cyclopharm Limited | -4.7 Million AUD | 92.81% |
EMVision Medical Devices Ltd | -2.72 Million AUD | 87.617% |
Nova Eye Medical Limited | -8.79 Million AUD | 96.155% |
HeraMED Limited | -6.78 Million AUD | 95.017% |
Imricor Medical Systems, Inc. | -22.62 Million AUD | 98.506% |
ImpediMed Limited | -19.79 Million AUD | 98.292% |
InhaleRx Limited | -1.44 Million AUD | 76.581% |
LBT Innovations Limited | -3.74 Million AUD | 90.963% |
Micro-X Limited | -9.76 Million AUD | 96.539% |
Neurotech International Limited | -5.06 Million AUD | 93.332% |
OncoSil Medical Limited | -11.91 Million AUD | 97.163% |
PolyNovo Limited | 5.26 Million AUD | 106.425% |
Respiri Limited | -7.12 Million AUD | 95.259% |
SomnoMed Limited | -12.24 Million AUD | 97.239% |
Universal Biosensors, Inc. | -6.74 Million AUD | 94.986% |
Uscom Limited | -2.07 Million AUD | 83.709% |
Visioneering Technologies, Inc. | -5.06 Million AUD | 93.325% |